APLT — Applied Therapeutics Share News
0.000.00%
Last trade - 00:00- $15.67m
- $3.73m
- $0.46m
Brief: Applied Therapeutics Names Les Funtleyder As Chief Financial Officer, Principal Financial Officer Effective November 20, 2023
Applied Therapeutics Inc expected to post a loss of 26 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Comcast, Apple, Lockheed Martin
U.S. STOCKS ON THE MOVE-Applied Therapeutics, Salesforce, Palisade Bio
Applied Therapeutics jumps on plans to submit marketing application for metabolic disorder drug
Brief: Applied Therapeutics Files For Offer And Sell Shares Of Common Stock Of Up To $75 Million
Applied Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Applied Therapeutics Net Income USD -29.577 Mln
Applied Therapeutics Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Applied Therapeutics' Steven Ortega To Resign As Interim Principal Financial Officer
U.S. STOCKS ON THE MOVE-Ralph Lauren, American Airlines, Illumina
U.S. STOCKS ON THE MOVE-NVIDIA, e.l.f. Beauty, Dish Network
Brief: Applied Therapeutics Genetic Disorder Drug At-007 Receives Orphan Medicinal Product Designation In Europe
Applied Therapeutics up as genetic disorder drug gains 'orphan' tag in Europe
Brief: Applied Therapeutics Inc Files For Mixed Shelf Of Up To $300 Million - SEC Filing
Brief: Applied Therapeutics Reports First Quarter 2023 Financial Results
Applied Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Applied Therapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Booking Holdings, Coca-Cola, Zebra Technologies